Niacin and Niacinamide are effective vitamins of which the latter is the physiologically active form of the former i.e. Niacin, popularly known as vitamin B3. They provide protection against various diseases like Pellagra and Melanoma. They are used to enhance animal nutrition and reduce Ketosis. Although, they have proven health benefits, adverse side effects have surfaced restricting their consumption. Niacin is gaining popularity on pretext of treating hyperphosphatemia.
Niacin and Niacinamide are naturally occurring nutrients that can be found in meat, fish, yeast, beans and green vegetables. They can be produced in different forms like powder, granular and liquid. Growth of Niacin and Niacinamide industry can be attributed to its application in multiple areas and number of end uses like human nutrition, animal nutrition, pharmaceuticals, cosmeceuticals and many others. Global Niacin and Niacinamide landscape is anticipated to grow at ̴5% CAGR for the forecast period 2019-2027. Many factors like increasing healthcare expenditure, inclination towards healthy eating, increased cosmeceutical products demand and protection against various disease give positive momentum to the Niacin and Niacinamide industry on global level.
Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=4290
Schizophrenia treatment possible with vitamin 3 intake
Niacin and Niacinamide have shown some promising advances in treatment of Schizophrenia and further researches are being carried out in this direction. The main reason behind Schizophrenia is known to be biochemical imbalance. Schizophrenic toxin is derived from Adrenochrome that is expected to be reduced by the intake of Niacinamide. Vitamin B3 supplements like Niacinamide are prescribed to all types of Schizophrenia patients owing to its positive impact.
Niacin and Niacianmide’s global industry is also driven by its property of enhancing nutrition in animals and reducing Ketosis in dairy cattle. Both the factors result in higher milk production. However, increased production has its own side effects like elevated blood ketone and reduction in blood-glucose level. Several lactation trials have been conducted with Niacin. The result indicates that Niacin supplemented cows produce more milk with greater fat percentage. Small Niacin doses are administered to dairy cattle during peak lactation to prevent occurrence of Ketosis related physiological symptoms. Elsewhere, Niacin is gaining traction amongst physicians for its potential to treat hyperphosphatemia. It is eyed as a cost-effective alternative that can be used as an add-on therapy for phosphorous management in dialysis patients.
Read Report Overview- https://www.factmr.com/report/4290/niacin-and-niacinamide-market
Niacin and Niacinamide have no impact on Heart conditions
Studies about Niacin and Niacinamide consumption have highlighted its adverse effects. Consumption of both the chemicals by ageing population had no significant effect on health conditions like heart attacks and stroke attacks. Clinical trials prove that Niacin is not related to triglyceride levels and cardiovascular outcomes. The global Niacin and Niacinamide industry is alarmed by such findings as it can have negative impact on the overall sale.
Europe is accounted for one-fourth of the global Niacin and Niacinamide industry. Increase in unhealthy consumption pattern and physical inactivity amongst the citizen has increased the obese population. Government is promoting high nutrition Niacin and Niacinamide supplemented food for its citizen which is the major reason behind the strong presence of Niacin and Niacinamide industry in the region. Major key players in Niacin and niciamide industry are Lonza Group AG, BASF SE, Koninklijke DSM N.V. and Evonik Industries.
Request research methodology- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4290